Remote Haptic Rehabilitation for Parkinson's Disease
Enhancing Parkinson's Disease Rehabilitation Through Remote Haptic Guidance: Field Study
2 other identifiers
interventional
20
1 country
1
Brief Summary
Individuals with Parkinson's Disease (PD) often have motor difficulties that can negatively impact daily activities and their quality of life. Research has shown that to slow the progression of these symptoms, patients should partake in effective physical rehabilitation. However, effective physical rehabilitation has many barriers, including timing, cost, and other personal or system-level challenges. The purpose of this study is to evaluate the haptic remote rehabilitation system for patients with PD using a randomized controlled trial (RCT) in a field environment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedStudy Start
First participant enrolled
March 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
June 5, 2026
June 1, 2026
1.3 years
February 26, 2026
June 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
System Usability Scale (SUS)
This scale evaluates participants' perceived usability of the device and the haptic feedback. It consists of 10 items, each scored on a 5-point Likert scale (0-4). The total raw score is converted to a scale of 0-100. A higher score will indicate better usability. A score of 68 is considered average usability. Scores above 68 reflect above average usability, while scores below 68 reflect below-average usability.
At the end of the trial in week 8
Arm movement accuracy, speed, and smoothness
Each handheld device (both with and without haptic) are equipped with Intertial Measurement Units (IMUs). The data from the IMUs will be used to measure the movement accuracy, speed, and smoothness of the arm. Data recording will start during enrollment as baseline. Whenever participants complete any sessions during the 8-week trial period, data from the IMUs will be recorded to calculate movement accuracy, speed, and smoothness. We will compare these measures across the trial period to determine performance changes in the participants.
From enrollment to the end of intervention at 8 weeks
Secondary Outcomes (3)
Outcome Expectations of Exercise Scale (OEES)
At the end of the trial in week 8
Self-Efficacy Scale (SES)
At the end of the trial in week 8
Parkinson's Disease Questionnaire (PDQ-8)
At baseline (Week 0)
Study Arms (2)
Haptic group
EXPERIMENTALParticipants will receive a handheld device that can provide haptic feedback to guide them in performing different movement tasks. Each participant will be asked to participate in sessions lasting up to one hour, twice/week, for an 8-week period. Participants will be asked to perform typical upper-body movement tasks performed in rehabilitation sessions based on their functional capabilities. This includes "Full Extension Circles", "Shoulder Press", "Full Lateral Movement", and "Random Target Matching" activity. The haptic device will provide directional guidance to support the participants in completing these movement tasks.
Non-haptic group
SHAM COMPARATORParticipants will receive a handheld device similar to the haptic group. However, this device will not provide any haptic feedback. Each participant will be asked to participate in sessions lasting up to one hour, twice/week, for an 8-week period. Participants will be asked to perform typical upper-body movement tasks performed in rehabilitation sessions based on their functional capabilities. This includes "Full Extension Circles", "Shoulder Press", "Full Lateral Movement", and "Random Target Matching" activity. Participants will be asked to hold the handheld device during the tasks; however, they will not receive any haptic feedback from the device.
Interventions
Participants will receive a custom-made handheld haptic device, which will be used to perform selected movement tasks. The device can generate the feeling of directional feedback.
Participants will receive a handheld device similar to the haptic group. However, the device in this intervention will not provide any haptic feedback.
Eligibility Criteria
You may qualify if:
- Over 18 years old
- Diagnosed with PD
You may not qualify if:
- Hoehn and Yahr stage outside 1-3
- Lives outside the 48 contiguous states in the USA
- Unable to move hands and head without assistance
- Unable to remain seated in an upright position for up to an hour
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Tech
Blacksburg, Virginia, 24060, United States
Related Publications (8)
Garzo, A., Jung, J. H., Arcas-Ruiz-Ruano, J., Perry, J. C., & Keller, T. (2022). ArmAssist: A telerehabilitation solution for upper-limb rehabilitation at home. IEEE Robotics & Automation Magazine, 30(1), 62-71.
BACKGROUNDDockx K, Bekkers EM, Van den Bergh V, Ginis P, Rochester L, Hausdorff JM, Mirelman A, Nieuwboer A. Virtual reality for rehabilitation in Parkinson's disease. Cochrane Database Syst Rev. 2016 Dec 21;12(12):CD010760. doi: 10.1002/14651858.CD010760.pub2.
PMID: 28000926BACKGROUNDLanger A, Gassner L, Flotz A, Hasenauer S, Gruber J, Wizany L, Pokan R, Maetzler W, Zach H. How COVID-19 will boost remote exercise-based treatment in Parkinson's disease: a narrative review. NPJ Parkinsons Dis. 2021 Mar 8;7(1):25. doi: 10.1038/s41531-021-00160-3.
PMID: 33686074BACKGROUNDZaman MS, Ghahari S, McColl MA. Barriers to Accessing Healthcare Services for People with Parkinson's Disease: A Scoping Review. J Parkinsons Dis. 2021;11(4):1537-1553. doi: 10.3233/JPD-212735.
PMID: 34308913BACKGROUNDXia R, Mao ZH. Progression of motor symptoms in Parkinson's disease. Neurosci Bull. 2012 Feb;28(1):39-48. doi: 10.1007/s12264-012-1050-z.
PMID: 22233888BACKGROUNDMarras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM; Parkinson's Foundation P4 Group. Prevalence of Parkinson's disease across North America. NPJ Parkinsons Dis. 2018 Jul 10;4:21. doi: 10.1038/s41531-018-0058-0. eCollection 2018.
PMID: 30003140BACKGROUNDGBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
PMID: 30287051BACKGROUNDTysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1.
PMID: 28150045BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sol Lim, Ph.D.
Virginia Polytechnic Institute and State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be blindly assigned to one of the groups to reduce bias.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor at the Grado Department of Industrial and Systems Engineering
Study Record Dates
First Submitted
February 26, 2026
First Posted
March 9, 2026
Study Start
March 25, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
June 5, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share